Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B217e7c319f475cbacb5cf83b54b065b4> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B217e7c319f475cbacb5cf83b54b065b4 NCIT_P378 "NCI" @default.
- B217e7c319f475cbacb5cf83b54b065b4 type Axiom @default.
- B217e7c319f475cbacb5cf83b54b065b4 annotatedProperty IAO_0000115 @default.
- B217e7c319f475cbacb5cf83b54b065b4 annotatedSource NCIT_C185488 @default.
- B217e7c319f475cbacb5cf83b54b065b4 annotatedTarget "An indication that the RTK2-type molecular signature for pediatric high grade glioma was detected in a sample. This signature occurs more frequently in supratentorial than infratentorial gliomas and co-occurs with expression of both wild-type histone H3 and wild-type IDH. The RTK2-type molecular signature is characterized by the following molecular abnormalities (in order of most to least frequent) homozygous deletion of chromosome 9p, TERT promoter mutation, EGFR gene amplification, TP53 gene mutation, loss of chromosome 10q, gain of chromosome 7 and CDK4/6 mutations. This signature may rarely include MYCN gene amplification and PDGFRA gene amplification. Additionally, MGMT promoter methylation and loss of ATRX protein expression are not characteristics of this signature." @default.